Application of Graphene and its Derivatives in Cancer Diagnosis and Treatment

Drug Research ◽  
2017 ◽  
Vol 67 (12) ◽  
pp. 681-687 ◽  
Author(s):  
S. Ghanbarzadeh ◽  
H. Hamishehkar
Keyword(s):  
Cancer Diagnosis ◽  
Targeted Drug Delivery ◽  
High Selectivity ◽  
High Efficiency ◽  
Volume Ratio ◽  
Biological Properties ◽  
Diagnosis And Treatment ◽  
Therapeutic Effects ◽  
Pharmaceutical Sciences ◽  
Small Molecule Drugs

AbstractAlthough chemotherapies are successful in some cases, systemic toxicity could be simultaneously observed due to the lack of drugs selectivity to cancerous tissues, leading to the failure of the chemotherapies. Furthermore, the therapeutic effects will be significantly improved if the anticancer drugs could be delivered to cancer cells with high selectivity. In recent years, there have been many advances in the field of diagnosis and treatment of cancer as a result of the development of novel materials with noticeable and often unique properties. Nanoparticles have unique biological properties, owing to their small size and large surface area-to-volume ratio, which allow them to bind, absorb, and carry compounds such as small molecule drugs, DNA, RNA, proteins, and probes with high efficiency. In the course of the last decade, Graphene and its derivatives have attracted growing interest in medicinal and pharmaceutical sciences, and many studies have focused on the potential of Graphene and its derivatives as carriers for targeted drug delivery intended for cancer diagnosis and therapies. In the present study, we will review the characteistics and application of Graphene and its different derivatives and finally discuss the opportunities, limitations, and challenges in this encouraging field.

Role of Nanoparticles in Pharmacotherapy of Cancer Therapy

2016 ◽  
Vol 9 (1) ◽  
pp. 3073-3081
Author(s):  
Anupam Roy
Keyword(s):  
Side Effects ◽  
High Efficiency ◽  
Volume Ratio ◽  
Surface Characteristics ◽  
Biological Properties ◽  
Administration Routes ◽  
Small Molecule Drugs ◽  
Hydrophobic Substances ◽  
High Carrier

Despite several dozen medications, millions of people are dying every year due to cancer. Additionally, the survival patients suffer from various serious side effects due to the use of available anticancerdrugs. The development of nanoparticle based drugs seems to be effective providing low side effects and targeted action on cancer cells. Nanoparticles are particles between 1 and 100 nanometers in size. Nanoparticles have unique biological properties given their small size and large surface area-to-volume ratio, which allows them to bind, absorb, and carry compounds such as small molecule drugs, DNA, RNA, proteins, and probes with high efficiency. Their tunable size, shape, and surface characteristics also enable them to have high stability, high carrier capacity, greater ability to incorporate both hydrophilic and hydrophobic substances, and compatibility with different administration routes, thereby making them highly attractive in many aspects of oncology.

scholarly journals Advances in the use of nanocarriers for cancer diagnosis and treatment

2016 ◽  
Vol 14 (1) ◽  
pp. 99-103 ◽  
Author(s):  
Débora Braga Vieira ◽  
Lionel Fernel Gamarra
Keyword(s):  
Drug Delivery ◽  
Cancer Diagnosis ◽  
Targeted Drug Delivery ◽  
Drug Delivery Systems ◽  
Surface Engineering ◽  
Diagnosis And Treatment ◽  
Pharmacological Properties ◽  
Clinical Use ◽  
Targeted Drug ◽  
Future Work

ABSTRACT The use of nanocarriers as drug delivery systems for therapeutic or imaging agents can improve the pharmacological properties of commonly used compounds in cancer diagnosis and treatment. Advances in the surface engineering of nanoparticles to accommodate targeting ligands turned nanocarriers attractive candidates for future work involving targeted drug delivery. Although not targeted, several nanocarriers have been approved for clinical use and they are currently used to treat and/or diagnosis various types of cancers. Furthermore, there are several formulations, which are now in various stages of clinical trials. This review examined some approved formulations and discussed the advantages of using nanocarriers in cancer therapy.

PubChem and ChEMBL Beyond Lipinski

2019 ◽  
Author(s):  
Jean-Louis Reymond ◽  
Mahendra Awale ◽  
Daniel Probst ◽  
Alice Capecchi
Keyword(s):  
Nearest Neighbor ◽  
Molecular Shape ◽  
Biological Properties ◽  
Web Based ◽  
Large Molecules ◽  
Interactive Tools ◽  
Small Molecule Drugs ◽  
Pubchem Database ◽  
Nearest Neighbor Searches ◽  
Insight Into

<p>Seven million of the currently 94 million entries in the PubChem database break at least one of the four Lipinski constraints for oral bioavailability, 183,185 of which are also found in the ChEMBL database. These non-Lipinski PubChem (NLP) and ChEMBL (NLC) subsets are interesting because they contain new modalities that can display biological properties not accessible to small molecule drugs. Unfortunately, the current search tools in PubChem and ChEMBL are designed for small molecules and are not well suited to explore these subsets, which therefore remain poorly appreciated. Herein we report MXFP (macromolecule extended atom-pair fingerprint), a 217-D fingerprint tailored to analyze large molecules in terms of molecular shape and pharmacophores. We implement MXFP in two web-based applications, the first one to visualize NLP and NLC interactively using Faerun (http://faerun.gdb.tools/), the second one to perform MXFP nearest neighbor searches in NLP (http://similaritysearch.gdb.tools/). We show that these tools provide a meaningful insight into the diversity of large molecules in NLP and NLC. The interactive tools presented here are publicly available at http://gdb.unibe.ch and can be used freely to explore and better understand the diversity of non-Lipinski molecules in PubChem and ChEMBL.</p>

Recent Advances of Silver Nanoparticles in Cancer Diagnosis and Treatment

2020 ◽  
Vol 20 (11) ◽  
pp. 1276-1287 ◽  
Author(s):  
Tran Q. Huy ◽  
Pham T.M. Huyen ◽  
Anh-Tuan Le ◽  
Matteo Tonezzer
Keyword(s):  
Silver Nanoparticles ◽  
Cancer Treatment ◽  
Cancer Diagnosis ◽  
Essential Role ◽  
Review Paper ◽  
Diagnosis And Treatment ◽  
Antimicrobial Material ◽  
Pathogenic Agents ◽  
New Generation ◽  
Carrier Systems

Background: Silver nanoparticles (AgNPs) are well-known as a promising antimicrobial material; they have been widely used in many commercial products against pathogenic agents. Despite a growing concern regarding the cytotoxicity, AgNPs still have attracted considerable interest worldwide to develop a new generation of diagnostic tool and effective treatment solution for cancer cells. Objective: This paper aims to review the advances of AgNPs applied for cancer diagnosis and treatment. Methods: The database has been collected, screened and analysed through up-to-date scientific articles published from 2007 to May 2019 in peer-reviewed international journals. Results: The findings of the database have been analysed and divided into three parts of the text that deal with AgNPs in cancer diagnosis, their cytotoxicity, and the role as carrier systems for cancer treatment. Thanks to their optical properties, high conductivity and small size, AgNPs have been demonstrated to play an essential role in enhancing signals and sensitivity in various biosensing platforms. Furthermore, AgNPs also can be used directly or developed as a drug delivery system for cancer treatment. Conclusion: The review paper will help readers understand more clearly and systematically the role and advances of AgNPs in cancer diagnosis and treatment.

scholarly journals Child development at 6 years after maternal cancer diagnosis and treatment during pregnancy

2020 ◽  
Vol 138 ◽  
pp. 57-67 ◽  
Author(s):  
Tineke Vandenbroucke ◽  
Magali Verheecke ◽  
Mathilde van Gerwen ◽  
Kristel Van Calsteren ◽  
Michael J. Halaska ◽  
...  
Keyword(s):  
Child Development ◽  
Cancer Diagnosis ◽  
Diagnosis And Treatment

scholarly journals Microbial Metabolites in Colorectal Cancer: Basic and Clinical Implications

Metabolites ◽  
2021 ◽  
Vol 11 (3) ◽  
pp. 159
Author(s):  
Yao Peng ◽  
Yuqiang Nie ◽  
Jun Yu ◽  
Chi Chun Wong
Keyword(s):  
Colorectal Cancer ◽  
Gut Microbiota ◽  
Cancer Diagnosis ◽  
Intestinal Tract ◽  
Clinical Applications ◽  
Diagnosis And Treatment ◽  
Clinical Implications ◽  
Microbial Metabolites ◽  
Colorectal Tumorigenesis ◽  
Technology Studies

Colorectal cancer (CRC) is one of the leading cancers that cause cancer-related deaths worldwide. The gut microbiota has been proved to show relevance with colorectal tumorigenesis through microbial metabolites. By decomposing various dietary residues in the intestinal tract, gut microbiota harvest energy and produce a variety of metabolites to affect the host physiology. However, some of these metabolites are oncogenic factors for CRC. With the advent of metabolomics technology, studies profiling microbiota-derived metabolites have greatly accelerated the progress in our understanding of the host-microbiota metabolism interactions in CRC. In this review, we briefly summarize the present metabolomics techniques in microbial metabolites researches and the mechanisms of microbial metabolites in CRC pathogenesis, furthermore, we discuss the potential clinical applications of microbial metabolites in cancer diagnosis and treatment.

scholarly journals The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatment

Cell ◽  
2021 ◽  
Vol 184 (7) ◽  
pp. 1661-1670
Author(s):  
Henry Rodriguez ◽  
Jean Claude Zenklusen ◽  
Louis M. Staudt ◽  
James H. Doroshow ◽  
Douglas R. Lowy
Keyword(s):  
Cancer Diagnosis ◽  
Diagnosis And Treatment ◽  
Precision Oncology
Sign in / Sign up

Export Citation Format

Share Document